[Federal Register Volume 63, Number 148 (Monday, August 3, 1998)]
[Rules and Regulations]
[Page 41188]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 21 CFR Part 510


Animal Drugs, Feeds, and Related Products; Change of Sponsor Name

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect the change of sponsor name from Rhone-
Poulenc Chemicals, Ltd., to Rhodia Limited.

EFFECTIVE DATE: August 3, 1998.

FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary 
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-827-0213.

SUPPLEMENTARY INFORMATION: Rhone-Poulenc Chemicals, Ltd., P.O. Box 46, 
St. Andrews Rd., Avonmouth, Bristol BS119YF, England, UK, has informed 
FDA of a change of sponsor name to Rhodia, Limited. Accordingly, the 
agency is amending 21 CFR 510.600(c)(1) and (c)(2) to reflect the 
change of sponsor name.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

    1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


Sec. 510.600  [Amended]

    2. Section 510.600 Names, addresses, and drug labeler codes of 
sponsors of approved applications is amended in the table in paragraph 
(c)(1) by removing the entry for ``Rhone-Poulenc Chemicals, Ltd.,'' and 
by alphabetically adding an entry for ``Rhodia Limited''; and in the 
table in paragraph (c)(2) in the entry for ''059258'' by removing the 
sponsor name for ``Rhone-Poulenc Chemicals, Ltd.,'' and adding in its 
place ``Rhodia Limited''.


    Dated: July 10, 1998.
Margaret Ann Miller,
Acting Director, Office of New Animal Drug EvaluationCenter for 
Veterinary Medicine.
[FR Doc. 98-20532 Filed 7-31-98; 8:45 am]
BILLING CODE 4160-01-F